| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.07e-06 | 303 | 26 | 6 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 5.57e-06 | 562 | 26 | 7 | GO:0003712 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 6.71e-05 | 61 | 26 | 3 | GO:0030374 | |
| GeneOntologyMolecularFunction | histone methyltransferase binding | 2.46e-04 | 18 | 26 | 2 | GO:1990226 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 5.43e-04 | 1160 | 26 | 7 | GO:0030674 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 1.37e-03 | 1356 | 26 | 7 | GO:0060090 | |
| GeneOntologyMolecularFunction | chromatin binding | 2.36e-03 | 739 | 26 | 5 | GO:0003682 | |
| GeneOntologyBiologicalProcess | autonomic nervous system development | 4.21e-05 | 50 | 28 | 3 | GO:0048483 | |
| GeneOntologyCellularComponent | npBAF complex | 1.67e-04 | 14 | 29 | 2 | GO:0071564 | |
| HumanPheno | Short finger | 2.42e-06 | 325 | 12 | 7 | HP:0009381 | |
| HumanPheno | Aplasia/Hypoplasia of fingers | 5.40e-06 | 366 | 12 | 7 | HP:0006265 | |
| HumanPheno | Brachydactyly (hand) | 1.59e-05 | 430 | 12 | 7 | HP:0100667 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the hand | 6.95e-05 | 538 | 12 | 7 | HP:0005927 | |
| HumanPheno | Synostosis of joints | 7.43e-05 | 212 | 12 | 5 | HP:0100240 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the upper limbs | 1.04e-04 | 572 | 12 | 7 | HP:0006496 | |
| HumanPheno | Brachydactyly | 2.87e-04 | 670 | 12 | 7 | HP:0001156 | |
| HumanPheno | Short digit | 2.93e-04 | 672 | 12 | 7 | HP:0011927 | |
| Domain | TF_AP2 | 2.16e-05 | 5 | 28 | 2 | IPR004979 | |
| Domain | TF_AP2_C | 2.16e-05 | 5 | 28 | 2 | IPR013854 | |
| Domain | TF_AP-2 | 2.16e-05 | 5 | 28 | 2 | PF03299 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 3.15e-05 | 42 | 21 | 3 | M48237 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_ACTIVITY_OF_TFAP2_AP_2_FAMILY_TRANSCRIPTION_FACTORS | 7.56e-05 | 9 | 21 | 2 | MM15509 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_ACTIVITY_OF_TFAP2_AP_2_FAMILY_TRANSCRIPTION_FACTORS | 9.44e-05 | 10 | 21 | 2 | M27764 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 1.15e-04 | 11 | 21 | 2 | MM15510 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 1.38e-04 | 12 | 21 | 2 | M27765 | |
| Pathway | REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS | 2.19e-04 | 15 | 21 | 2 | M27766 | |
| Pathway | REACTOME_SPECIFICATION_OF_THE_NEURAL_PLATE_BORDER | 2.84e-04 | 17 | 21 | 2 | M48248 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 3.61e-04 | 95 | 21 | 3 | M48268 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS | 3.95e-04 | 20 | 21 | 2 | M27237 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 6.72e-04 | 26 | 21 | 2 | MM15502 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 8.38e-04 | 29 | 21 | 2 | M48076 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 9.58e-04 | 31 | 21 | 2 | M39522 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 1.05e-03 | 137 | 21 | 3 | M48232 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 1.44e-03 | 38 | 21 | 2 | M27757 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 12694203 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 29715367 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 31115525 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 31744881 | ||
| Pubmed | Cloning and characterization of a second AP-2 transcription factor: AP-2 beta. | 6.71e-07 | 2 | 29 | 2 | 7555706 | |
| Pubmed | AP-2α/AP-2β Transcription Factors Are Key Regulators of Epidermal Homeostasis. | 6.71e-07 | 2 | 29 | 2 | 38237728 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 32769099 | ||
| Pubmed | Comparative analysis of AP-2 alpha and AP-2 beta gene expression during murine embryogenesis. | 6.71e-07 | 2 | 29 | 2 | 8989526 | |
| Pubmed | AP2 transcription factor induces apoptosis in retinoblastoma cells. | 6.71e-07 | 2 | 29 | 2 | 20607706 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 9758708 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 11553286 | ||
| Pubmed | Comprehensive analysis of the expression and prognosis for TFAP2 in human lung carcinoma. | 2.01e-06 | 3 | 29 | 2 | 32462520 | |
| Pubmed | Initiation of fibronectin fibrillogenesis is an enzyme-dependent process. | 2.01e-06 | 3 | 29 | 2 | 37148241 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 17196169 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 8661133 | ||
| Pubmed | Transcriptional activation by Myc is under negative control by the transcription factor AP-2. | 2.01e-06 | 3 | 29 | 2 | 7729426 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 25667979 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 7559606 | ||
| Pubmed | 2.08e-06 | 30 | 29 | 3 | 24073291 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 3.30e-06 | 123 | 29 | 4 | 26912792 | |
| Pubmed | The AP-2 adaptor beta2 appendage scaffolds alternate cargo endocytosis. | 4.02e-06 | 4 | 29 | 2 | 18843039 | |
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 21829553 | ||
| Pubmed | The interaction of KCTD1 with transcription factor AP-2alpha inhibits its transactivation. | 4.02e-06 | 4 | 29 | 2 | 19115315 | |
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 9765260 | ||
| Pubmed | Regulation of AP-2 and apoptosis in developing eye in a vitamin A-deficiency model. | 4.02e-06 | 4 | 29 | 2 | 12749383 | |
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 12711551 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 6.08e-06 | 877 | 29 | 7 | 20211142 | |
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 16672719 | ||
| Pubmed | AP-2α and AP-2β regulate dorsal interneuron specification in the spinal cord. | 6.70e-06 | 5 | 29 | 2 | 27984181 | |
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 12228234 | ||
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 16957052 | ||
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 35468900 | ||
| Pubmed | Transcription factor AP-2 interacts with the SUMO-conjugating enzyme UBC9 and is sumolated in vivo. | 6.70e-06 | 5 | 29 | 2 | 12072434 | |
| Pubmed | 8.00e-06 | 591 | 29 | 6 | 15231748 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 9.90e-06 | 351 | 29 | 5 | 38297188 | |
| Pubmed | Regulation of the CUL3 Ubiquitin Ligase by a Calcium-Dependent Co-adaptor. | 9.95e-06 | 50 | 29 | 3 | 27716508 | |
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 33460639 | ||
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 27259519 | ||
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 12586840 | ||
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 15569994 | ||
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 38816354 | ||
| Pubmed | AP-2alpha transcription factor is required for early morphogenesis of the lens vesicle. | 1.00e-05 | 6 | 29 | 2 | 9918694 | |
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 11694877 | ||
| Pubmed | RUNX3 suppresses metastasis and stemness by inhibiting Hedgehog signaling in colorectal cancer. | 1.00e-05 | 6 | 29 | 2 | 31278361 | |
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 23540691 | ||
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 32427396 | ||
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 17643423 | ||
| Pubmed | TFAP2 paralogs regulate midfacial development in part through a conserved ALX genetic pathway. | 1.41e-05 | 7 | 29 | 2 | 38063857 | |
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 20691033 | ||
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 14572467 | ||
| Pubmed | AP-2ε Expression in Developing Retina: Contributing to the Molecular Diversity of Amacrine Cells. | 1.41e-05 | 7 | 29 | 2 | 29467543 | |
| Pubmed | 1.77e-05 | 396 | 29 | 5 | 26687479 | ||
| Pubmed | 1.87e-05 | 8 | 29 | 2 | 11319856 | ||
| Pubmed | Ihh and Runx2/Runx3 signaling interact to coordinate early chondrogenesis: a mouse model. | 1.87e-05 | 8 | 29 | 2 | 23383321 | |
| Pubmed | 1.87e-05 | 8 | 29 | 2 | 21276792 | ||
| Pubmed | 1.87e-05 | 8 | 29 | 2 | 31638440 | ||
| Pubmed | 1.87e-05 | 8 | 29 | 2 | 11744733 | ||
| Pubmed | TFAP2 paralogs regulate melanocyte differentiation in parallel with MITF. | 2.41e-05 | 9 | 29 | 2 | 28249010 | |
| Pubmed | 2.41e-05 | 9 | 29 | 2 | 39052671 | ||
| Pubmed | Regulation of the noradrenaline neurotransmitter phenotype by the transcription factor AP-2beta. | 2.41e-05 | 9 | 29 | 2 | 18424435 | |
| Pubmed | 2.41e-05 | 9 | 29 | 2 | 23834954 | ||
| Pubmed | 2.41e-05 | 9 | 29 | 2 | 12504852 | ||
| Pubmed | 3.01e-05 | 10 | 29 | 2 | 20807571 | ||
| Pubmed | Fgf8 is required for pharyngeal arch and cardiovascular development in the mouse. | 3.01e-05 | 10 | 29 | 2 | 12223417 | |
| Pubmed | The Nab2 and Stat6 genes share a common transcription termination region. | 3.01e-05 | 10 | 29 | 2 | 9126479 | |
| Pubmed | 3.01e-05 | 10 | 29 | 2 | 18691547 | ||
| Pubmed | 3.01e-05 | 10 | 29 | 2 | 26434918 | ||
| Pubmed | 3.01e-05 | 10 | 29 | 2 | 23942202 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 3.51e-05 | 457 | 29 | 5 | 32344865 | |
| Pubmed | 3.68e-05 | 11 | 29 | 2 | 19141316 | ||
| Pubmed | 3.68e-05 | 11 | 29 | 2 | 15668330 | ||
| Pubmed | 3.68e-05 | 11 | 29 | 2 | 29604273 | ||
| Pubmed | Sonic hedgehog is required for cardiac outflow tract and neural crest cell development. | 3.68e-05 | 11 | 29 | 2 | 15936751 | |
| Pubmed | 3.68e-05 | 11 | 29 | 2 | 38750698 | ||
| Pubmed | 3.73e-05 | 777 | 29 | 6 | 35844135 | ||
| Pubmed | 3.80e-05 | 78 | 29 | 3 | 28611094 | ||
| Pubmed | 4.41e-05 | 12 | 29 | 2 | 20150232 | ||
| Pubmed | 4.41e-05 | 12 | 29 | 2 | 36577057 | ||
| Pubmed | 4.41e-05 | 12 | 29 | 2 | 36497119 | ||
| Pubmed | 4.41e-05 | 12 | 29 | 2 | 25964075 | ||
| Pubmed | 4.41e-05 | 12 | 29 | 2 | 11734557 | ||
| Pubmed | 4.58e-05 | 83 | 29 | 3 | 28794006 | ||
| Pubmed | 5.21e-05 | 13 | 29 | 2 | 9271117 | ||
| Pubmed | 5.21e-05 | 13 | 29 | 2 | 21539825 | ||
| Pubmed | 5.21e-05 | 13 | 29 | 2 | 17724084 | ||
| Pubmed | 6.07e-05 | 14 | 29 | 2 | 28912684 | ||
| Pubmed | Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome. | 6.07e-05 | 14 | 29 | 2 | 36289231 | |
| Pubmed | 6.07e-05 | 14 | 29 | 2 | 29262337 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 6.60e-05 | 861 | 29 | 6 | 36931259 | |
| Pubmed | 7.00e-05 | 15 | 29 | 2 | 35333176 | ||
| Pubmed | 7.00e-05 | 15 | 29 | 2 | 23785148 | ||
| Pubmed | Disrupting hedgehog and WNT signaling interactions promotes cleft lip pathogenesis. | 7.00e-05 | 15 | 29 | 2 | 24590292 | |
| Pubmed | 8.00e-05 | 16 | 29 | 2 | 26968737 | ||
| Pubmed | 8.00e-05 | 16 | 29 | 2 | 25242040 | ||
| Pubmed | 8.00e-05 | 16 | 29 | 2 | 19233133 | ||
| Pubmed | 9.06e-05 | 17 | 29 | 2 | 32986815 | ||
| Pubmed | 9.06e-05 | 17 | 29 | 2 | 18330926 | ||
| Pubmed | Multiple essential roles for primary cilia in heart development. | 9.06e-05 | 17 | 29 | 2 | 23351706 | |
| Pubmed | 1.02e-04 | 18 | 29 | 2 | 32901292 | ||
| Pubmed | Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions. | 1.06e-04 | 110 | 29 | 3 | 37219487 | |
| Interaction | DAZL interactions | 1.55e-06 | 145 | 28 | 5 | int:DAZL | |
| Interaction | ETV4 interactions | 2.42e-06 | 69 | 28 | 4 | int:ETV4 | |
| Interaction | TCF7 interactions | 4.18e-06 | 23 | 28 | 3 | int:TCF7 | |
| Interaction | PDCD6 interactions | 8.23e-06 | 204 | 28 | 5 | int:PDCD6 | |
| Interaction | ERG interactions | 1.27e-05 | 223 | 28 | 5 | int:ERG | |
| Interaction | NUP35 interactions | 2.13e-05 | 424 | 28 | 6 | int:NUP35 | |
| Interaction | SMG7 interactions | 7.02e-05 | 319 | 28 | 5 | int:SMG7 | |
| Interaction | EGR2 interactions | 8.74e-05 | 171 | 28 | 4 | int:EGR2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 2.38e-03 | 423 | 29 | 3 | chr12q13 | |
| Coexpression | GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_UP | 6.47e-05 | 198 | 29 | 4 | M6166 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_6_7WK_UP | 6.60e-05 | 199 | 29 | 4 | M2155 | |
| Coexpression | GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN | 6.60e-05 | 199 | 29 | 4 | M5348 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_6_7WK_UP | 6.60e-05 | 199 | 29 | 4 | MM991 | |
| Coexpression | GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN | 6.60e-05 | 199 | 29 | 4 | M5350 | |
| Coexpression | GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_UP | 6.73e-05 | 200 | 29 | 4 | M9397 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_DN | 6.92e-05 | 398 | 29 | 5 | M7514 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_DN | 9.02e-05 | 421 | 29 | 5 | MM985 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#5_top-relative-expression-ranked_200 | 9.45e-05 | 65 | 29 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200_k5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.05e-04 | 182 | 29 | 4 | gudmap_developingGonad_e16.5_ovary_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_500 | 1.28e-04 | 72 | 29 | 3 | gudmap_developingGonad_e18.5_epididymis_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#4_top-relative-expression-ranked_500 | 1.45e-04 | 75 | 29 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_500 | 2.57e-04 | 91 | 29 | 3 | gudmap_developingGonad_e14.5_ epididymis_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_500 | 2.57e-04 | 91 | 29 | 3 | gudmap_developingGonad_e16.5_epididymis_500_k4 | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 4.34e-06 | 170 | 29 | 4 | 9e328e1f904c77dcce8aee4df775d7f0ac725775 | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Control / Disease condition and Cell class | 5.56e-06 | 181 | 29 | 4 | f3e1d8fe5cf1eba19e51c3680a55306cae687fe9 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.02e-06 | 192 | 29 | 4 | 0219093e7921a0db78053aee13ec480b520f5662 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.02e-06 | 192 | 29 | 4 | f14ee74ac3275601749a23c5efe39c2413a62e1a | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.22e-04 | 149 | 29 | 3 | 6e9ca280a599d96f8956ef26f2a46b9484de5488 | |
| ToppCell | normal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.37e-04 | 155 | 29 | 3 | 08295584395e8d9cfc1b1648f98754b3ac53e587 | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 164 | 29 | 3 | 4e1861382c9e93856da19303474c8975c19706d2 | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 164 | 29 | 3 | 467ad12884b70d243988174ae960ee2b7b6cfb0c | |
| ToppCell | Club_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.68e-04 | 166 | 29 | 3 | a440aa338aa0c6cd0b5800dfa7e83f8ca16fce1a | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.68e-04 | 166 | 29 | 3 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.71e-04 | 167 | 29 | 3 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.71e-04 | 167 | 29 | 3 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | 3'_v3|World / Manually curated celltypes from each tissue | 2.06e-04 | 178 | 29 | 3 | 42502f14d9c756df8104900ac6484477b885d3d9 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.06e-04 | 178 | 29 | 3 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 182 | 29 | 3 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.27e-04 | 184 | 29 | 3 | 235890e8b424f4386b6ea52d173d20a00898df73 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.31e-04 | 185 | 29 | 3 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-04 | 185 | 29 | 3 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-04 | 185 | 29 | 3 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.31e-04 | 185 | 29 | 3 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.35e-04 | 186 | 29 | 3 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.35e-04 | 186 | 29 | 3 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Trm_Th1/Th17|Lung / Manually curated celltypes from each tissue | 2.46e-04 | 189 | 29 | 3 | f43960506ed3e699e910ec7711c1113e2e9b80d1 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.50e-04 | 190 | 29 | 3 | 9a43d1e7e1291cb23db6466967ec70c41fc0880c | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.50e-04 | 190 | 29 | 3 | 805ce69e7e91a6a8f04e8ccbd4bfca4e804be43d | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.50e-04 | 190 | 29 | 3 | 12931a56d18c6dc79bd21148255dace8115abf0c | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.50e-04 | 190 | 29 | 3 | 423b54c6d48d6981a9522043252239303dccaf04 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.50e-04 | 190 | 29 | 3 | 81e7d4f97b958b4ed14298a77104ef31a6ec6c91 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.50e-04 | 190 | 29 | 3 | a1b19028c36d192352bc8a7f187790f4b56cfe17 | |
| ToppCell | CV-Moderate-0|Moderate / Virus stimulation, Condition and Cluster | 2.54e-04 | 191 | 29 | 3 | 6776bcc4c1915f0c1062002ff7746f20ceb725f4 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.58e-04 | 192 | 29 | 3 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.58e-04 | 192 | 29 | 3 | 985fff79e645f0670eee8a0c8db08b5f7822e27a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal-choroid_plexus/mesenchymal-like_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 2.62e-04 | 193 | 29 | 3 | b6f5a85210e60798205eaf5884cdb540f549d08a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 2.62e-04 | 193 | 29 | 3 | e1de67ddada87229f5db0ec193a6da8745a86a64 | |
| ToppCell | tumor_Lung-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.74e-04 | 196 | 29 | 3 | 7aa6778b78a8549dd4d0a5278ef8017334b00c38 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.78e-04 | 197 | 29 | 3 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.78e-04 | 197 | 29 | 3 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 2.78e-04 | 197 | 29 | 3 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | (3)_Chondrocytes-(30)_Chondro|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.78e-04 | 197 | 29 | 3 | a07ab2564ca7d577fd47f444dd7b0c25556e9fc4 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.82e-04 | 198 | 29 | 3 | 5024d43b4cf7dea305ed911f1e123ca7fd44e990 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.82e-04 | 198 | 29 | 3 | 162881a04a981741a0e26e32e0c3c694282701c6 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.82e-04 | 198 | 29 | 3 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.82e-04 | 198 | 29 | 3 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.86e-04 | 199 | 29 | 3 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | healthy_donor|World / Disease condition, Lineage, Cell class and subclass | 2.90e-04 | 200 | 29 | 3 | afd4d5609adaa470e3d880f8be4a4d55e162b3d6 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 2.90e-04 | 200 | 29 | 3 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.90e-04 | 200 | 29 | 3 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.52e-06 | 174 | 29 | 5 | 1659_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.66e-06 | 176 | 29 | 5 | 6932_DN | |
| Drug | ginsenoside Rb2 | 3.23e-06 | 23 | 29 | 3 | CID000073598 | |
| Drug | Ipratropium bromide [22254-24-6]; Up 200; 9.8uM; HL60; HG-U133A | 4.29e-06 | 194 | 29 | 5 | 1769_UP | |
| Drug | Phenethicillin potassium salt [132-93-4]; Up 200; 10uM; MCF7; HT_HG-U133A | 4.74e-06 | 198 | 29 | 5 | 6239_UP | |
| Drug | DB08464 | 1.24e-05 | 113 | 29 | 4 | CID011373270 | |
| Drug | AP 0 | 2.34e-05 | 6 | 29 | 2 | CID005494408 | |
| Drug | Fp 3 | 3.28e-05 | 7 | 29 | 2 | CID000203335 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 6.16e-05 | 170 | 29 | 4 | 1050_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 6.45e-05 | 172 | 29 | 4 | 1072_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 7.05e-05 | 176 | 29 | 4 | 7499_DN | |
| Drug | Tiaprofenic acid [33005-95-7]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 1.03e-04 | 194 | 29 | 4 | 4171_DN | |
| Drug | Dirithromycin [62013-04-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 1.03e-04 | 194 | 29 | 4 | 7446_DN | |
| Drug | Kawain [500-64-1]; Down 200; 17.4uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 29 | 4 | 7369_DN | |
| Drug | Dilazep dihydrochloride [20153-98-4]; Up 200; 6uM; PC3; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 3665_UP | |
| Drug | Iocetamic acid [16034-77-8]; Down 200; 6.6uM; HL60; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 3022_DN | |
| Drug | Ornidazole [16773-42-5]; Up 200; 18.2uM; PC3; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 5064_UP | |
| Drug | (R)-Propranolol hydrochloride [13071-11-9]; Up 200; 13.6uM; PC3; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 5814_UP | |
| Drug | S(-)-terguride hydrogen maleate [37686-85-4]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 6473_UP | |
| Drug | Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 6259_DN | |
| Drug | Megestrol acetate [595-33-5]; Down 200; 10.4uM; HL60; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 3091_DN | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; HL60; HG-U133A | 1.13e-04 | 199 | 29 | 4 | 2024_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 1.13e-04 | 199 | 29 | 4 | 6963_DN | |
| Drug | Metrizamide [31112-62-6]; Down 200; 5uM; HL60; HT_HG-U133A | 1.13e-04 | 199 | 29 | 4 | 1318_DN | |
| Disease | Clinodactyly | 5.59e-06 | 4 | 29 | 2 | C4551485 | |
| Disease | Clinodactyly of fingers | 5.59e-06 | 4 | 29 | 2 | C0265610 | |
| Disease | sleep disorder (implicated_via_orthology) | 5.10e-05 | 11 | 29 | 2 | DOID:535 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | 6.41e-05 | 1074 | 29 | 7 | C0006142 | |
| Disease | Cleft upper lip | 6.76e-04 | 39 | 29 | 2 | C0008924 | |
| Disease | Celiac Disease | 9.81e-04 | 47 | 29 | 2 | C0007570 | |
| Disease | sitting height ratio | 1.15e-03 | 51 | 29 | 2 | EFO_0007118 | |
| Disease | basophil count | 1.22e-03 | 483 | 29 | 4 | EFO_0005090 | |
| Disease | Diffuse Large B-Cell Lymphoma | 1.34e-03 | 55 | 29 | 2 | C0079744 | |
| Disease | hemoglobin A1 measurement | 1.60e-03 | 520 | 29 | 4 | EFO_0007629 | |
| Disease | psoriasis vulgaris | 1.65e-03 | 61 | 29 | 2 | EFO_1001494 | |
| Disease | asthma, endometriosis | 2.41e-03 | 74 | 29 | 2 | EFO_0001065, MONDO_0004979 | |
| Disease | psoriasis, type 2 diabetes mellitus | 2.48e-03 | 75 | 29 | 2 | EFO_0000676, MONDO_0005148 | |
| Disease | Glioblastoma | 2.74e-03 | 79 | 29 | 2 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 3.09e-03 | 84 | 29 | 2 | C0334588 | |
| Disease | calcium measurement | 3.16e-03 | 628 | 29 | 4 | EFO_0004838 | |
| Disease | left ventricular structural measurement | 3.39e-03 | 88 | 29 | 2 | EFO_0008205 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QPPPQPFPGDPYSYN | 496 | Q07001 | |
| PYFPPPYQPIYPQSQ | 56 | P05549 | |
| QPYYSQQPQPPHLPP | 681 | Q8NFD5 | |
| PPPYQPLPYHQSQDP | 71 | Q92481 | |
| RMNSSPYQPPPPQPY | 666 | Q9HBD1 | |
| QYPTQPTYPVQPPGN | 6 | Q15038 | |
| PTYPVQPPGNPVYPQ | 11 | Q15038 | |
| PYPQPPFQPSPYGQP | 41 | Q7Z429 | |
| RQYQQAPPQPFPPAP | 476 | Q4ZG55 | |
| QQPPPGPESYVPPYR | 391 | Q15742 | |
| QRQPPPPQHPGPYQE | 81 | Q8NBC4 | |
| YPGPQQPSYPFPQPP | 846 | Q8WUM4 | |
| YPQPPQPYPAQRPPG | 1061 | O43896 | |
| QPYPAQRPPGPRYPP | 1066 | O43896 | |
| PPPPPPPSSSYYQNQ | 1546 | Q8IZD2 | |
| PPQYLQSGPYTQPPP | 856 | P08151 | |
| SPRPYYPQTPNNRPP | 1216 | Q14686 | |
| AAVYQPQPHPQPPPY | 291 | P02751 | |
| PPYVGPPQQYPVQPP | 76 | O43432 | |
| SPPQPSYSQPPYNQG | 751 | Q9BUJ2 | |
| TYLPPPYPGAPQNQS | 306 | Q13761 | |
| QPVPEQPLYPQPYQP | 41 | P02808 | |
| YPRPKPRPQPQPGNS | 66 | P55808 | |
| RPPPPPYNCRYGSQP | 276 | Q9HCM1 | |
| LYPGPNQPPIAPYQT | 351 | O94933 | |
| QPNPNPTGPYFAYPI | 81 | Q93073 | |
| QPPPPQYDYPPQSTF | 71 | P0CJ78 | |
| PPYRPPQQGPPQQYS | 251 | Q15532 | |
| YQGPPPQQGYPPQQQ | 336 | Q15532 | |
| GPPQPPQQRPYGYDQ | 396 | Q15532 | |
| PPVQPYPPCQQKYPP | 56 | Q9BYE4 | |
| TQVPPYPQPQPYQPA | 866 | O94979 | |
| YPQPQPYQPAQPYPF | 871 | O94979 | |
| TQPGQYPAPNPPRPL | 426 | Q9ULJ6 | |
| YPAPNPPRPLTSPNY | 431 | Q9ULJ6 |